MyAverix Finance
US · Healthcare
Cosmo Pharmaceuticals N.V (CMOPF)
Drug Manufacturers - General
Cosmo Pharmaceuticals N.V (CMOPF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CMOPF
Cosmo Pharmaceuticals N.V (CMOPF) — FAQ
What is CMOPF's P/E ratio?
The price-to-earnings (P/E) ratio for Cosmo Pharmaceuticals N.V (CMOPF) is 18.00 (data as of 2026-05-23).
Does Cosmo Pharmaceuticals N.V pay a dividend?
Dividend yield is not available in the current snapshot for Cosmo Pharmaceuticals N.V (CMOPF). Check the MyAverix Finance app for the latest dividend data.
What sector is Cosmo Pharmaceuticals N.V in?
Cosmo Pharmaceuticals N.V (CMOPF) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is CMOPF listed on?
CMOPF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.